| Eli Lilly’s Novel Financing Approach to R&D |
Abstract
pdf
html
|
|
Helen Scrutton |
|
| Valeant Licenses Epilepsy Drug to GSK |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Novosom Smarticles® to Encapsulate Isis Antisense Drugs |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
| QLT Continues to Divest its Portfolio |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Bristol-Myers Squibb Deal Provides PDL with Much Needed Boost |
Abstract
pdf
html
|
|
Helen Scrutton |
|
| Cytos Signs Vaccines Deal with Pfizer |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Archemix in Yet Another Deal for its Aptamer Technology |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
| CSL Seeks to Solidfy its Position by Acquiring Talecris |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| The Medicines Company Acquires Curacyte and its Lead Antithrombotic |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Valeant Pharmaceuticals’ De-Globalisation Strategy Sees the Sale of European Operations |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
| Negotiations Begin Between Bristol-Myers Squibb and ImClone |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| US Election Will Impact New Drug Development Worldwide Forever |
Abstract
html
|
|
Fintan Walton |
|
| Cel-Sci’s Multikine Could be Distributed by Teva in Turkey and Israel |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
